Huons acquires ‘generic’ approval of 0.9% Sodium Chloride Injection USP 5mL/10mL from U.S. FDA

Huons(CEO Gi-An Eom), a subsidiary of Huons Global, announced on the 24^th that 0.9% Sodium Chloride Injection USP 5mL/10mL acquired a generic drug approval(ANDA) from the U.S. FDA.

Huons took a process of the ANDA(Abbreviated New Drug Application) for its 0.9% Sodium Chloride Injection USP 5mL/10mL in the U.S., and acquired the ANDA approval from the U.S. FDA for the first time as a Korea-manu...